Evolent Health (NYSE:EVH – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Needham & Company LLC in a ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Evolent Health (EVH – Research Report) and Staar Surgical ...

Evolent Health, Inc. has a 52 week low of $9.56 and a 52 week high of $35.00. The firm’s fifty day moving average is $11.04 and its 200 day moving average is $19.69.

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Evolent Health ...

Evolent Health Inc . (NYSE:EVH) stock has reached its 52-week low, trading at $9.55, marking a significant downturn for the company within the healthcare sector. Despite the current market sentiment, ...

RBC Capital analyst Sean Dodge reiterated a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of $270.00. The ...

Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week.

Jan. 15, 2025 — Research has established a clear link between racial and ethnic disparities in maternal heart health and higher risks of preterm birth, preeclampsia and cardiovascular issues for ...

Jan. 30, 2025 — A green alga that grows in lakes and rivers could be the next 'superfood' -- helping scientists to tackle global food security challenges while promoting environmental ...